- Proceeds will support development of lead clinical programs, RBN-2397 and RBN-3143, while advancing early-stage pipeline derived from Ribon’s BEACON + platform CAMBRIDGE, Mass.--(BUSINESS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results